Rochester General Hospital is the first U.S. clinical trial site of AquaPass - a system designed to significantly help congestive heart failure and end-stage renal disease patients suffering from fluid overload.
For more information about interviews, news stories, or press releases, reach out to:
Cristina Domingues Public Relations Advisor (585) 414-7895 Email